Selected research
Industry Research
Artificial Retina Industry Research Report 2026
Market perspective
The global Artificial Retina market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Artificial Retina is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Artificial Retina is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Artificial Retina is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Artificial Retina include Axorus, Bionic Vision Technologies, Labtician Ophthalmics, Inc., Lambda Vision, Inc., Nano Retina, Optobionics, Vivani Medical Inc.(Second Sight Medical Products, Inc.) and Pixium Vision, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Artificial Retina market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Artificial Retina Market by Company
Axorus
Bionic Vision Technologies
Labtician Ophthalmics, Inc.
Lambda Vision, Inc.
Nano Retina
Optobionics
Vivani Medical Inc.(Second Sight Medical Products, Inc.)
Pixium Vision
Artificial Retina Segment by Type
Subretinal Implantation
Extraretinal Implantation
Artificial Retina Segment by Application
Blind People
Patients with Retinal Degenerative Diseases
Artificial Retina Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Retina market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Retina and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Retina.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Artificial Retina manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Artificial Retina by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Artificial Retina in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Subretinal Implantation
- Extraretinal Implantation
Applications
- Blind People
- Patients with Retinal Degenerative Diseases
Companies covered
- Axorus
- Bionic Vision Technologies
- Labtician Ophthalmics, Inc.
- Lambda Vision, Inc.
- Nano Retina
- Optobionics
- Vivani Medical Inc.(Second Sight Medical Products, Inc.)
- Pixium Vision
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Artificial Retina Market Size (2021-2032)
- 2.2.2 Global Artificial Retina Sales (2021-2032)
- 2.2.3 Global Artificial Retina Market Average Price (2021-2032)
- 2.3 Artificial Retina by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Subretinal Implantation
- 2.3.3 Extraretinal Implantation
- 2.4 Artificial Retina by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Blind People
- 2.4.3 Patients with Retinal Degenerative Diseases
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Artificial Retina Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Artificial Retina Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Artificial Retina Revenue of Manufacturers (2021-2026)
- 3.4 Global Artificial Retina Average Price by Manufacturers (2021-2026)
- 3.5 Global Artificial Retina Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Artificial Retina, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Artificial Retina, Product Type & Application
- 3.8 Global Manufacturers of Artificial Retina, Established Date
- 3.9 Global Artificial Retina Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Axorus
- 4.1.1 Axorus Company Information
- 4.1.2 Axorus Business Overview
- 4.1.3 Axorus Artificial Retina Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Axorus Artificial Retina Product Portfolio
- 4.1.5 Axorus Recent Developments
- 4.2 Bionic Vision Technologies
- 4.2.1 Bionic Vision Technologies Company Information
- 4.2.2 Bionic Vision Technologies Business Overview
- 4.2.3 Bionic Vision Technologies Artificial Retina Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bionic Vision Technologies Artificial Retina Product Portfolio
- 4.2.5 Bionic Vision Technologies Recent Developments
- 4.3 Labtician Ophthalmics, Inc.
- 4.3.1 Labtician Ophthalmics, Inc. Company Information
- 4.3.2 Labtician Ophthalmics, Inc. Business Overview
- 4.3.3 Labtician Ophthalmics, Inc. Artificial Retina Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Labtician Ophthalmics, Inc. Artificial Retina Product Portfolio
- 4.3.5 Labtician Ophthalmics, Inc. Recent Developments
- 4.4 Lambda Vision, Inc.
- 4.4.1 Lambda Vision, Inc. Company Information
- 4.4.2 Lambda Vision, Inc. Business Overview
- 4.4.3 Lambda Vision, Inc. Artificial Retina Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Lambda Vision, Inc. Artificial Retina Product Portfolio
- 4.4.5 Lambda Vision, Inc. Recent Developments
- 4.5 Nano Retina
- 4.5.1 Nano Retina Company Information
- 4.5.2 Nano Retina Business Overview
- 4.5.3 Nano Retina Artificial Retina Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Nano Retina Artificial Retina Product Portfolio
- 4.5.5 Nano Retina Recent Developments
- 4.6 Optobionics
- 4.6.1 Optobionics Company Information
- 4.6.2 Optobionics Business Overview
- 4.6.3 Optobionics Artificial Retina Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Optobionics Artificial Retina Product Portfolio
- 4.6.5 Optobionics Recent Developments
- 4.7 Vivani Medical Inc.(Second Sight Medical Products, Inc.)
- 4.7.1 Vivani Medical Inc.(Second Sight Medical Products, Inc.) Company Information
- 4.7.2 Vivani Medical Inc.(Second Sight Medical Products, Inc.) Business Overview
- 4.7.3 Vivani Medical Inc.(Second Sight Medical Products, Inc.) Artificial Retina Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Vivani Medical Inc.(Second Sight Medical Products, Inc.) Artificial Retina Product Portfolio
- 4.7.5 Vivani Medical Inc.(Second Sight Medical Products, Inc.) Recent Developments
- 4.8 Pixium Vision
- 4.8.1 Pixium Vision Company Information
- 4.8.2 Pixium Vision Business Overview
- 4.8.3 Pixium Vision Artificial Retina Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pixium Vision Artificial Retina Product Portfolio
- 4.8.5 Pixium Vision Recent Developments
5 Global Artificial Retina Market Scenario by Region
- 5.1 Global Artificial Retina Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Artificial Retina Sales by Region: 2021-2032
- 5.2.1 Global Artificial Retina Sales by Region: 2021-2026
- 5.2.2 Global Artificial Retina Sales by Region: 2027-2032
- 5.3 Global Artificial Retina Revenue by Region: 2021-2032
- 5.3.1 Global Artificial Retina Revenue by Region: 2021-2026
- 5.3.2 Global Artificial Retina Revenue by Region: 2027-2032
- 5.4 North America Artificial Retina Market Facts & Figures by Country
- 5.4.1 North America Artificial Retina Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Artificial Retina Sales by Country (2021-2032)
- 5.4.3 North America Artificial Retina Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Artificial Retina Market Facts & Figures by Country
- 5.5.1 Europe Artificial Retina Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Artificial Retina Sales by Country (2021-2032)
- 5.5.3 Europe Artificial Retina Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Artificial Retina Market Facts & Figures by Country
- 5.6.1 Asia Pacific Artificial Retina Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Artificial Retina Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Artificial Retina Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Artificial Retina Market Facts & Figures by Country
- 5.7.1 South America Artificial Retina Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Artificial Retina Sales by Country (2021-2032)
- 5.7.3 South America Artificial Retina Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Artificial Retina Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Artificial Retina Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Artificial Retina Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Artificial Retina Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Artificial Retina Sales by Type (2021-2032)
- 6.1.1 Global Artificial Retina Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Artificial Retina Sales Market Share by Type (2021-2032)
- 6.2 Global Artificial Retina Revenue by Type (2021-2032)
- 6.2.1 Global Artificial Retina Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Artificial Retina Revenue Market Share by Type (2021-2032)
- 6.3 Global Artificial Retina Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Artificial Retina Sales by Application (2021-2032)
- 7.1.1 Global Artificial Retina Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Artificial Retina Sales Market Share by Application (2021-2032)
- 7.2 Global Artificial Retina Revenue by Application (2021-2032)
- 7.2.1 Global Artificial Retina Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Artificial Retina Revenue Market Share by Application (2021-2032)
- 7.3 Global Artificial Retina Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Artificial Retina Value Chain Analysis
- 8.1.1 Artificial Retina Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Artificial Retina Production Mode & Process
- 8.2 Artificial Retina Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Artificial Retina Distributors
- 8.2.3 Artificial Retina Customers
9 Global Artificial Retina Analyzing Market Dynamics
- 9.1 Artificial Retina Industry Trends
- 9.2 Artificial Retina Industry Drivers
- 9.3 Artificial Retina Industry Opportunities and Challenges
- 9.4 Artificial Retina Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst